J Child Neurol. 2006;21(1):31-44.

Children in our series with subtotal removal have always had meningioma regrowth. This datum might be erroneously interpreted as the malignant behavior of the tumor. The analysis of 419 cases ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss ...

Lutetium 177 dotatate showed activity and met the PFS end point in patients with surgery- or radiation-refractory grade 2/3 meningioma, per a phase 2 trial presented at ASTRO 2024. TREATMENT WITH ...

Petroclival meningiomas, despite their typically benign pathology, present significant surgical challenges due to their proximity to critical anatomical structures. The complex anatomy and difficult ...

gDepartment of Pathology and Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA, hStanford Cancer Institute, Stanford University School ...

Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...

Pembrolizumab is under clinical development by Merck and currently in Phase II for Metastatic Breast Cancer. According to GlobalData, Phase II drugs for Metastatic Breast Cancer have a 32% phase ...

A delay such as this is recommended to exclude deaths related to severe pathology to which HRT use is unlikely to have contributed. The length of the delay will be varied for certain cancers (such as ...

A pathology report found that Clark didn't have a schwannoma like she was initially told, but a meningioma. Both types of tumors are slow-growing and can recur, so Clark will have regular follow ...